Product Image

Melatonin 1.0 mg Orange Flavor

Source Naturals Sleep Science
4.7
★ ★ ★ ★ ★
(482 ratings)
Melatonin 1 mg
Product Image
Score87
A well-dosed orange dissolving melatonin option for sleep onset. It is simple and economical but does not provide sustained overnight support.
How scoring works
Quantity:100 Liquid(s) • (100 servings)
Goals:
Sleep Support

Score 87

A well-dosed orange dissolving melatonin option for sleep onset. It is simple and economical but does not provide sustained overnight support.
How scoring works
$6.65($0.06 per serving)
Pure Formulas
$ 6.65
Vitacost
$ 6.65
Pure Formulas
$ 6.65
iHerb
$ 6.65
Report prices

Analysis

A 1 mg melatonin unit sits comfortably within a cautious low-dose range. The orange-flavored dissolving format may be useful for people who want prompt bedtime delivery without swallowing a pill.

The formula contains no competing active ingredients, making dose and purpose easy to understand. Lack of sustained release limits its fit for people whose main concern is waking during the night.

One hundred servings provide convenient routine value. Orange flavor is the main preference factor compared with the otherwise similar peppermint option.

Who is it for
  • Adults seeking 1 mg melatonin
  • Users who prefer orange flavor
  • People wanting a dissolving bedtime format
Best for
  • Low-dose sleep-onset support
  • Prompt bedtime use
  • Good serving value

Pros

  • Cautious 1 mg amount
  • Single-unit serving
  • One hundred servings

Cons

  • No sustained-release design
  • No additional calming ingredients
  • Purity verification is not provided

Warnings

  • Melatonin may cause next-day drowsiness or vivid dreams even at a low amount
  • Avoid driving if morning alertness is reduced

Nutrient quality

95 Highest impact

The 1 mg amount is well aligned with low-dose sleep support. The dissolving format may support quicker onset but not overnight release.

.

Ingredient transparency

85 Highest impact

Active amounts are clear without a hidden blend. Complete directions and inactive ingredients remain unavailable.

.

Customer satisfaction

69 High impact

The supplied average is strong and supported by substantial volume. No review themes were provided, so consistency and purpose-specific experience cannot be assessed.

.

Value for money

99 Highest impact

A very low serving cost and clearly stated dose support value. Missing release tailoring and purity verification limit differentiation.

.
Report analysis

Goals

Sleep Support
Impact
High effect
B- Goal FitA- Strength of SupportD CoverageA- Formula Quality
Melatonin · 1 mg

The 1 mg melatonin lozenge uses a low amount that may support sleep timing or onset when circadian support is needed. Melatonin is a targeted sleep aid rather than a broad foundational-health ingredient.

The dissolving format may act relatively quickly, but no sustained-release feature supports sleep maintenance. Independent purity verification is not provided, and next-day drowsiness remains possible even at a low amount.

Study evidence
Melatonin Supportive 181 studies

Ingredients

IngredientAmount per serving
Melatonin
1 mg
Adults 18–50 Women
Report overview
Melatonin · 1 mg OverallScore75
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value

The low-dose lozenge fits the physiological range, and single-unit dosing makes use clear. Its dissolving format may support quicker onset, but no sustained-release technology is shown for sleep maintenance. Independent purity verification is not provided, while the cost per serving is very low.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Meta-analysis: melatonin for the treatment of primary sleep disorders.
    Ferracioli-Oda E; Qawasmi A; Bloch MH · PloS one · 2013
    Meta-analysis1,683 participants19 studies pooledSleep Support forMelatonin
  2. Efficacy on sleep parameters and tolerability of melatonin in individuals with sleep or mental disorders: A systematic review and meta-analysis.
    Salanitro M; Wrigley T; Ghabra H; de Haan E; Hill CM; Solmi M; Cortese S · Neuroscience and biobehavioral reviews · 2022
    Meta-analysis1,998 participants34 studies pooledSleep Support forMelatonin
  3. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
    Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW; Delayed Sleep on Melatonin (DelSoM) Study Group · PLoS medicine · 2019
    Randomized trial116 participantsSleep Support forMelatonin
  4. Melatonin treatment for age-related insomnia.
    Zhdanova IV; Wurtman RJ; Regan MM; Taylor JA; Shi JP; Leclair OU · The Journal of clinical endocrinology and metabolism · 2001
    Randomized trial30 participantsSleep Support forMelatonin
  5. The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis.
    Yousef O; Abouelmagd ME; Khaddam H; Shbani A; Yousef R; Meshref M; Hanafi I · Journal of sleep research · 2026
    Meta-analysis409 participants8 studies pooledSleep Support forMelatonin
  6. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N · BMC medicine · 2010
    Randomized trial791 participantsSleep Support forMelatonin
  7. Effects of exogenous melatonin on sleep: a meta-analysis.
    Brzezinski A; Vangel MG; Wurtman RJ; Norrie G; Zhdanova I; Ben-Shushan A; Ford I · Sleep medicine reviews · 2005
    Meta-analysis284 participants8 studies pooledSleep Support forMelatonin